Halozyme Therapeutics Inc. Common Stock vs Powell Industries — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B), while Powell Industries trades at $192.66 (market cap $6.89B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Powell Industries pays a 0.19% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Powell Industries for 5 Days on average.
| HALO | POWL | |
|---|---|---|
Market Cap | $12.58B | $6.89B |
Volume | 2,179,278 | 728,725 |
Sector | Health | Industrials |
52-Week High | $115.22 | $322.05 |
52-Week Low | $61.63 | $94.02 |
Typical Hold Time | 1 Days | 5 Days |
Enterprise Value | $14.49B | $6.26B |
Dividend Yield | — | 0.19% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →